Structure of SALL4 zinc finger domain reveals link between AT-rich DNA binding and Okihiro syndrome
Open accessPublished version of a preprint
The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 26 of the 54 sources its claims cite were checked for support.
Abstract
Spalt-like 4 (SALL4) maintains vertebrate embryonic stem cell identity and is required for the development of multiple organs, including limbs. Mutations in SALL4 are associated with Okihiro syndrome, and SALL4 is also a known target of thalidomide. SALL4 protein has a distinct preference for AT-rich sequences, recognised by a pair of zinc fingers at the C-terminus. However, unlike many characterised zinc finger proteins, SALL4 shows flexible recognition with many different combinations of AT-rich sequences being targeted. SALL4 interacts with the NuRD corepressor complex which potentially mediates repression of AT-rich genes. We present a crystal structure of SALL4 C-terminal zinc fingers with an AT-rich DNA sequence, which shows that SALL4 uses small hydrophobic and polar side chains to provide flexible recognition in the major groove. Missense mutations reported in patients that lie within the C-terminal zinc fingers reduced overall binding to DNA but not the preference for AT-rich sequences. Furthermore, these mutations altered association of SALL4 with AT-rich genomic sites, providing evidence that these mutations are likely pathogenic.
Overview
CoChat Summary
TL;DR
The paper shows that the SALL4 ZFC4 zinc-finger domain binds AT-rich DNA through a conserved interface of small polar and hydrophobic residues, with an X-ray crystal structure and biochemical tests explaining sequence preference. It also shows that patient missense mutations in ZFC4 reduce DNA binding and disrupt heterochromatin localization, linking impaired AT-rich DNA recognition to Okihiro syndrome.
Key findings
- The ZFC4–DNA crystal structure was solved at 2.76 Å resolution, with final Rwork/Rfree values of 24.7%/25.4%, and showed ZFC4 contacting bases in the major groove while DNA adopts a compressed minor groove and slightly expanded major groove.
- ZFC4 recognizes AT-rich sequences using small polar/hydrophobic residues; in binding assays, WT protein had an apparent Kd of 0.76 µM, while I897S and the I897S,V925S double mutant had reduced binding (Kd 4.8 and 5.0 µM), whereas V925S retained binding (Kd 0.91 µM).
- Patient mutations in ZFC4 reduced DNA binding: R900W had an apparent Kd of 23 µM, and G921D binding was too weak to determine; both mutations also caused diffuse nuclear localization instead of DAPI-bright heterochromatin foci in NIH 3T3 cells.
- HT-SELEX showed WT and mutant ZFC4 proteins still preferred AT-rich motifs, but enrichment was much higher for WT; the top enriched motifs were exclusively A/T and enrichment tracked better with total A/T content than with consecutive A/T runs.
Methods
- The study combined structural, biochemical, sequencing-based, and cell-based approaches: X-ray crystallography of mouse SALL4 ZFC4 (residues 870–940) bound to a palindromic AT-rich oligonucleotide, SAXS, EMSA, HT-SELEX, and immunofluorescence in cells.
- For disease-relevant testing, the authors compared WT SALL4 with patient missense variants H898R, R900W, and G921D in NIH 3T3 fibroblasts, which lack endogenous SALL4 and SALL1.
- HT-SELEX was run in triplicate, with mutant and WT ZFC4 proteins, and analyzed by k-mer enrichment across cycles 1, 3, and 6; structural comparisons and binding analyses were used to interpret sequence specificity.
Limitations
- The crystal structure had high anisotropy and limited resolution (2.76 Å), and the authors note they could not fit structured water at the DNA-protein interface.
- The paper’s binding conclusions for some mutants are constrained by assay limits: for G921D, an EMSA dissociation constant could not be determined.
- Evident from the text: the work tests only a limited set of mutations and a single ZFC4 DNA motif/oligonucleotide context in the structural assay, so it does not establish all possible sequence or mutation effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure S2. Features of SALL4 ZFC4 are found in SALL1 and SALL3. (A) 2Fo-Fc map contoured at 1σ around the TGEKP sequence that connects Znf6 to Znf7. R900 of Znf6 hydrogen bonds with the backbone carbonyl group of T918. (B) Refined SALL4 ZFC4 chain L with palindromic DNA, showing the final 2Fo-Fc map contoured at 1σ. The view is of a plane through the A4(yellow)–T9(white) base pair. (C) Multiple protein sequence alignments of SALL4, SALL1, and SALL3 across vertebrates (Homo sapiens [HUMAN], Mus musculus [MOUSE], Gallus gallus [CHICK], Anolis carolinensis [ANOCA], Xenopus tropicalis [XENTR], Danio rerio [DANRE]), with Drosophila melanogaster Salr for reference. The sequences were aligned using MAFFT. Znf6 is highlighted green and Znf7 is highlighted blue. Reference sequence positions for each zinc finger are given above the alignment. DNA-binding residues are boxed in green and blue. Patient missense mutations are boxed in pink and orange and annotated above with human and (mouse) numbering. Secondary structure elements are shown below the sequence. Asterisks indicate residues that have previously been shown to alter SALL4 function in mouse cells. (D) Analysis of gnomAD variants (blue vertical lines) for SALL1 and SALL3 with domain organisation and numbering for domain boundaries below. The Vp values for SALL1 and SALL3 are given below the protein name, whereas VdVp values are given for the calculated domain boundaries. Source data are available for this figure.](https://figures.cochat.ai/paper-figures/ea9012e830a44b82807771f433077dd9/structure-of-sall4-zinc-finger-domain-reveals-link-between-at-rich-dna-binding-figure-4.jpg)







Verification
Claims the paper makes
18 Valid · 4 Not valid · 18 Not checked · 98 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“we extracted population missense mutations and calculated an overall missense depletion score for SALL4 protein (Vp) of 0.38 (Deak & Cook, 2022) (Fig 1A).”
§ Structure of SALL4 zinc finger domain reveals link between AT-rich DNA binding and Okihiro syndrome > Results > ZFC4 domain is depleted of population missense variants According to the gnomAD database (Karczewski et al, 2020), the loss-of-function observed/expected upper bound fraction (LOEUF) indicates that SALL4 is depleted of inactivating variants and under purifying selection (LOEUF = 0.101). This is consistent with the finding that SALL4 haploinsufficiency is responsible for an autosomal dominant disorder. To further understand the contribution of different SALL4 domains to function, we extracted population missense mutations and calculated an overall missense depletion score for SALL4 protein (Vp) of 0.38 (Deak & Cook, 2022) (Fig 1A). We then considered individual domains of SALL4 and calculated missense depletion relative to the whole protein (VdVp ratio), where a score of ≥1 would indicate that a single domain is not depleted of missense variants compared with the full protein sequence (Deak & Cook, 2022). Three regions were observed to be comparatively depleted of population missense mutations: the N-terminal NuRD binding motif (Lauberth & Rauchman, 2006) (VdVp = 0.22); a glutamine-rich (Q-rich) sequence that has been reported to participate in SALL protein homo- and heterodimer formation (VdVp = 0.50) (Sweetman et al, 2003); and ZFC4, which is essential for SALL4 function in mice (VdVp = 0.47) (Pantier et al, 2021) (Fig 1A). Missense depletion of these regions indicates that they are likely to contribute to the essential functions of SALL4. The two other zinc finger domain regions, ZFC1 and ZFC2, are less depleted (VdVp = 0.78 and 0.89, respectively). Indeed, the gnomAD database, which excludes individuals with severe pathological symptoms compared with the general population, reveals mutations in ZFC1 and ZFC2 (residues 382–432 and 566–648, respectively) that alter the cysteine and histidine residues that are essential for zinc finger integrity (C387Y: Znf1; C412S: Znf2; H644D: Znf5; H644L: Znf5). The absence of both these domains in the shorter SALL4B splice variant is also consistent with a specialised role for these ZFCs in SALL4 function. A number of likely pathogenic mutations have been reported for SALL4 in Okihiro syndrome patients (Kohlhase et al, 2002, 2003; Borozdin et al, 2004a, 2004b; Kohlhase et al, 2005; Diehl et al, 2015). We searched the literature and the ClinVar database for missense variants affecting SALL4 as these can inform on functional regions within SALL4 (Landrum et al, 2018).
What the sources say
- Partly supportedcites Deak & Cook, 2022 matched to “Missense Variants Reveal Functional Insights Into the Human ARID Family of Gene Regulators” (2022) sourceExperimental — accuracy not yet measured
The Results section (‘Genetic constraint in the ARID family’; page unavailable) defines Vp as the average density of missense variants for a protein, supporting the cited method. The paper does not report a Vp of 0.38 for SALL4; the citing sentence says its authors calculated that value themselves. (LLM, conf=0.83)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“SALL4 deficiency leads to peri-implantation lethality in mice (Sakaki-Yumoto et al, 2006) and increased neuronal differentiation potential in mouse ESCs (Miller et al, 2016), indicating that SALL4 helps maintain stem cell identity.”
§ Structure of SALL4 zinc finger domain reveals link between AT-rich DNA binding and Okihiro syndrome > Introduction Embryonic stem cells (ESCs) balance pluripotency with a development and differentiation program to generate distinct tissues within an organised body plan. Proteins involved in development are typically expressed transiently, at specific embryonic locations, and are absent from adult tissues or restricted to specific tissue progenitor cells. SALL4 is a protein of this type which is expressed both in ESCs and in later lineages during embryogenesis and plays critical roles in the development of various organs (Sweetman & Munsterberg, 2006). It is one of four spalt-like C2H2 zinc finger DNA-binding proteins in mouse and humans. SALL4 deficiency leads to peri-implantation lethality in mice (Sakaki-Yumoto et al, 2006) and increased neuronal differentiation potential in mouse ESCs (Miller et al, 2016), indicating that SALL4 helps maintain stem cell identity. Heterozygous SALL4 mutation in mice causes defects in multiple organs including the nervous system, limbs, kidneys, heart, and anorectal tract (Koshiba-Takeuchi et al, 2006; Sakaki-Yumoto et al, 2006). Consistent with the phenotypes of SALL4 haploinsufficiency in mice, patients with Okihiro syndrome, an autosomal dominant disorder caused by mutations in SALL4, also present a range of symptoms including limb defects, eye anomalies (Duane syndrome), vertebral malformations, hearing loss, kidney defects, heart anomalies, and anal stenosis (Al-Baradie et al, 2002; Kohlhase et al, 2002). Some Okihiro syndrome patients have a presentation similar to thalidomide embryopathy (Kohlhase et al, 2003); consistent with this, SALL4 is a cellular target of thalidomide, which facilitates binding of SALL4 to the CLR4CRBN E3 ubiquitin ligase that ubiquitylates SALL4 and leads to its destruction (Donovan et al, 2018; Matyskiela et al, 2018, 2020). SALL4 contains seven zinc fingers (Znfs) arranged in three clusters (Fig 1A). Sequence comparisons suggest that these are closely related to zinc finger clusters (ZFCs) 1, 2, and 4 of SALL1 and SALL3 (Sweetman & Munsterberg, 2006). Two SALL4 isoforms have been reported: SALL4A, which encompasses all three ZFCs, and SALL4B, which only has ZFC4. In ESCs, SALL4B is sufficient to maintain ESC identity in the absence of SALL4A (Rao et al, 2010). The roles of ZFC1 and ZFC2 are less well understood. However, SALL4A but not SALL4B can interact with the transcription factor PLZF in spermatogonial progenitor cells, suggesting a role for ZFC1 and/or ZFC2 in protein–protein interactions (Hobbs et al, 2012). Furthermore, ZFC1 and ZFC2 mediate SALL4 ubiquitination in the presence of thalidomide, leading to SALL4 degradation (Matyskiela et al, 2018). ZFC1 was reported to bind to 5-hydroxymethylcytosine (Xiong et al, 2016) and AT-rich DNA sequences in vitro (Ru et al, 2022). However, a SALL4 truncation lacking both ZFC1 and ZFC2 shows no defect in genome-wide chromatin binding in ESCs, suggesting that these ZFCs are largely dispensable for DNA binding in vivo (Pantier et al, 2021). We previously showed that SALL1, SALL3, and SALL4, which all encode ZFC4, are all selectively enriched on AT-rich DNA (Pantier et al, 2021). Similar to observations for SALL1 (Yamashita et al, 2007), ZFC4 of SALL4 is required for its localisation to mouse pericentric heterochromatin (Sakaki-Yumoto et al, 2006) and has a strong preference for a range of AT-rich DNA sequence motifs (Kong et al, 2021; Pantier et al, 2021). The molecular basis of this broad specificity is unknown, but there is evidence that it is essential for the ability of SALL4 to maintain stemness in ESCs by sensing differences in sequence composition in the genome (Pantier et al, 2021). Importantly, discrete mutation of ZFC4 leads to precocious ESC differentiation and embryonic lethality, phenocopying complete loss of SALL4 (Sakaki-Yumoto et al, 2006). To gain insight into how SALL4 selects AT-rich sequences, and the likely effect of missense mutations on DNA binding, we undertook a structural, biochemical, and cell-based analysis of ZFC4. We solved the X-ray crystal structure of SALL4 ZFC4 with an AT-rich sequence motif to gain insight into this broad sequence specificity. We also characterised two patient missense mutations that are likely to be deleterious and causative of Okihiro syndrome. We show that these mutations reduce SALL4 ZFC4 binding to AT-rich DNA, yet the proteins retain preference for AT-rich sequences. In cells, full-length mutant proteins fail to localise to heterochromatin. These results confirm that SALL4 binding to AT-rich sequences is fundamental to its in vivo function and that disruptions to this interaction contribute to disease presentation.
What the sources say
- Supportedcites Miller et al, 2016 matched to “Sall4 controls differentiation of pluripotent cells independently of the Nucleosome Remodelling and Deacetylation (NuRD) complex” (2016) source
In the Results section, under “Sall4 is dispensable for ESC self-renewal, but inhibits neural differentiation,” Sall4-null ESCs produced neurons by day 5 of a neuroectodermal differentiation protocol, whereas wild-type cultures did not during the first five days (Fig. 2A). This supports the attributed increase in neuronal differentiation potential. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Similar to observations for SALL1 (Yamashita et al, 2007), ZFC4 of SALL4 is required for its localisation to mouse pericentric heterochromatin (Sakaki-Yumoto et al, 2006) and has a strong preference for a range of AT-rich DNA sequence motifs (Kong et al, 2021; Pantier et al, 2021).”
§ Structure of SALL4 zinc finger domain reveals link between AT-rich DNA binding and Okihiro syndrome > Introduction Embryonic stem cells (ESCs) balance pluripotency with a development and differentiation program to generate distinct tissues within an organised body plan. Proteins involved in development are typically expressed transiently, at specific embryonic locations, and are absent from adult tissues or restricted to specific tissue progenitor cells. SALL4 is a protein of this type which is expressed both in ESCs and in later lineages during embryogenesis and plays critical roles in the development of various organs (Sweetman & Munsterberg, 2006). It is one of four spalt-like C2H2 zinc finger DNA-binding proteins in mouse and humans. SALL4 deficiency leads to peri-implantation lethality in mice (Sakaki-Yumoto et al, 2006) and increased neuronal differentiation potential in mouse ESCs (Miller et al, 2016), indicating that SALL4 helps maintain stem cell identity. Heterozygous SALL4 mutation in mice causes defects in multiple organs including the nervous system, limbs, kidneys, heart, and anorectal tract (Koshiba-Takeuchi et al, 2006; Sakaki-Yumoto et al, 2006). Consistent with the phenotypes of SALL4 haploinsufficiency in mice, patients with Okihiro syndrome, an autosomal dominant disorder caused by mutations in SALL4, also present a range of symptoms including limb defects, eye anomalies (Duane syndrome), vertebral malformations, hearing loss, kidney defects, heart anomalies, and anal stenosis (Al-Baradie et al, 2002; Kohlhase et al, 2002). Some Okihiro syndrome patients have a presentation similar to thalidomide embryopathy (Kohlhase et al, 2003); consistent with this, SALL4 is a cellular target of thalidomide, which facilitates binding of SALL4 to the CLR4CRBN E3 ubiquitin ligase that ubiquitylates SALL4 and leads to its destruction (Donovan et al, 2018; Matyskiela et al, 2018, 2020). SALL4 contains seven zinc fingers (Znfs) arranged in three clusters (Fig 1A). Sequence comparisons suggest that these are closely related to zinc finger clusters (ZFCs) 1, 2, and 4 of SALL1 and SALL3 (Sweetman & Munsterberg, 2006). Two SALL4 isoforms have been reported: SALL4A, which encompasses all three ZFCs, and SALL4B, which only has ZFC4. In ESCs, SALL4B is sufficient to maintain ESC identity in the absence of SALL4A (Rao et al, 2010). The roles of ZFC1 and ZFC2 are less well understood. However, SALL4A but not SALL4B can interact with the transcription factor PLZF in spermatogonial progenitor cells, suggesting a role for ZFC1 and/or ZFC2 in protein–protein interactions (Hobbs et al, 2012). Furthermore, ZFC1 and ZFC2 mediate SALL4 ubiquitination in the presence of thalidomide, leading to SALL4 degradation (Matyskiela et al, 2018). ZFC1 was reported to bind to 5-hydroxymethylcytosine (Xiong et al, 2016) and AT-rich DNA sequences in vitro (Ru et al, 2022). However, a SALL4 truncation lacking both ZFC1 and ZFC2 shows no defect in genome-wide chromatin binding in ESCs, suggesting that these ZFCs are largely dispensable for DNA binding in vivo (Pantier et al, 2021). We previously showed that SALL1, SALL3, and SALL4, which all encode ZFC4, are all selectively enriched on AT-rich DNA (Pantier et al, 2021). Similar to observations for SALL1 (Yamashita et al, 2007), ZFC4 of SALL4 is required for its localisation to mouse pericentric heterochromatin (Sakaki-Yumoto et al, 2006) and has a strong preference for a range of AT-rich DNA sequence motifs (Kong et al, 2021; Pantier et al, 2021). The molecular basis of this broad specificity is unknown, but there is evidence that it is essential for the ability of SALL4 to maintain stemness in ESCs by sensing differences in sequence composition in the genome (Pantier et al, 2021). Importantly, discrete mutation of ZFC4 leads to precocious ESC differentiation and embryonic lethality, phenocopying complete loss of SALL4 (Sakaki-Yumoto et al, 2006). To gain insight into how SALL4 selects AT-rich sequences, and the likely effect of missense mutations on DNA binding, we undertook a structural, biochemical, and cell-based analysis of ZFC4. We solved the X-ray crystal structure of SALL4 ZFC4 with an AT-rich sequence motif to gain insight into this broad sequence specificity. We also characterised two patient missense mutations that are likely to be deleterious and causative of Okihiro syndrome. We show that these mutations reduce SALL4 ZFC4 binding to AT-rich DNA, yet the proteins retain preference for AT-rich sequences. In cells, full-length mutant proteins fail to localise to heterochromatin. These results confirm that SALL4 binding to AT-rich sequences is fundamental to its in vivo function and that disruptions to this interaction contribute to disease presentation.
What the sources say
- Partly supportedcites Kong et al, 2021 matched to “Zinc finger protein SALL4 functions through an AT-rich motif to regulate gene expression” (2021) sourceExperimental — accuracy not yet measured
The Results section identifies ZFC4 as responsible for recognizing an AT-rich DNA sequence, and the Discussion says SALL4 binds through ZFC4. But the paper describes one highly specific consensus motif with little degeneracy, not a broad range of AT-rich motifs. (LLM, conf=0.87)
- Supportedcites Pantier et al, 2021 matched to “SALL4 controls cell fate in response to DNA base composition” (2021) source
The Results section, “SALL4 binds to short AT-rich motifs via C2H2 zinc-finger cluster 4,” reports that purified ZFC4 enriched multiple AT-rich sequences and favored A/T-only 5-mers over G/C-containing ones. It concludes that ZFC4 targets a broad range of short A/T motifs, directly supporting the cited claim. (LLM, conf=0.94)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Three regions were observed to be comparatively depleted of population missense mutations: the N-terminal NuRD binding motif (Lauberth & Rauchman, 2006) (VdVp = 0.22); a glutamine-rich (Q-rich) sequence that has been reported to participate in SALL protein homo- and heterodimer formation (VdVp = 0.50) (Sweetman et al, 2003); and ZFC4, which is essential for SALL4 function in mice (VdVp = 0.47) (P”
§ Structure of SALL4 zinc finger domain reveals link between AT-rich DNA binding and Okihiro syndrome > Results > ZFC4 domain is depleted of population missense variants According to the gnomAD database (Karczewski et al, 2020), the loss-of-function observed/expected upper bound fraction (LOEUF) indicates that SALL4 is depleted of inactivating variants and under purifying selection (LOEUF = 0.101). This is consistent with the finding that SALL4 haploinsufficiency is responsible for an autosomal dominant disorder. To further understand the contribution of different SALL4 domains to function, we extracted population missense mutations and calculated an overall missense depletion score for SALL4 protein (Vp) of 0.38 (Deak & Cook, 2022) (Fig 1A). We then considered individual domains of SALL4 and calculated missense depletion relative to the whole protein (VdVp ratio), where a score of ≥1 would indicate that a single domain is not depleted of missense variants compared with the full protein sequence (Deak & Cook, 2022). Three regions were observed to be comparatively depleted of population missense mutations: the N-terminal NuRD binding motif (Lauberth & Rauchman, 2006) (VdVp = 0.22); a glutamine-rich (Q-rich) sequence that has been reported to participate in SALL protein homo- and heterodimer formation (VdVp = 0.50) (Sweetman et al, 2003); and ZFC4, which is essential for SALL4 function in mice (VdVp = 0.47) (Pantier et al, 2021) (Fig 1A). Missense depletion of these regions indicates that they are likely to contribute to the essential functions of SALL4. The two other zinc finger domain regions, ZFC1 and ZFC2, are less depleted (VdVp = 0.78 and 0.89, respectively). Indeed, the gnomAD database, which excludes individuals with severe pathological symptoms compared with the general population, reveals mutations in ZFC1 and ZFC2 (residues 382–432 and 566–648, respectively) that alter the cysteine and histidine residues that are essential for zinc finger integrity (C387Y: Znf1; C412S: Znf2; H644D: Znf5; H644L: Znf5). The absence of both these domains in the shorter SALL4B splice variant is also consistent with a specialised role for these ZFCs in SALL4 function. A number of likely pathogenic mutations have been reported for SALL4 in Okihiro syndrome patients (Kohlhase et al, 2002, 2003; Borozdin et al, 2004a, 2004b; Kohlhase et al, 2005; Diehl et al, 2015). We searched the literature and the ClinVar database for missense variants affecting SALL4 as these can inform on functional regions within SALL4 (Landrum et al, 2018).
What the sources say
- Not checked — no full text of the sourcecites Lauberth & Rauchman, 2006 matched to “A Conserved 12-Amino Acid Motif in Sall1 Recruits the Nucleosome Remodeling and Deacetylase Corepressor Complex” (2006) source
- Could not verifycites Deak & Cook, 2022 matched to “Missense Variants Reveal Functional Insights Into the Human ARID Family of Gene Regulators” (2022) sourceExperimental — accuracy not yet measured
The Introduction describes Vd/Vp as a measure of missense depletion, but the passages from Results concern ARID-family proteins, not the N-terminal NuRD-binding motif. Searches for the motif, SALL proteins, and 0.22 found no passage reporting the claimed depletion or value. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“We previously showed that SALL1, SALL3, and SALL4, which all encode ZFC4, are all selectively enriched on AT-rich DNA (Pantier et al, 2021).”
§ Structure of SALL4 zinc finger domain reveals link between AT-rich DNA binding and Okihiro syndrome > Introduction Embryonic stem cells (ESCs) balance pluripotency with a development and differentiation program to generate distinct tissues within an organised body plan. Proteins involved in development are typically expressed transiently, at specific embryonic locations, and are absent from adult tissues or restricted to specific tissue progenitor cells. SALL4 is a protein of this type which is expressed both in ESCs and in later lineages during embryogenesis and plays critical roles in the development of various organs (Sweetman & Munsterberg, 2006). It is one of four spalt-like C2H2 zinc finger DNA-binding proteins in mouse and humans. SALL4 deficiency leads to peri-implantation lethality in mice (Sakaki-Yumoto et al, 2006) and increased neuronal differentiation potential in mouse ESCs (Miller et al, 2016), indicating that SALL4 helps maintain stem cell identity. Heterozygous SALL4 mutation in mice causes defects in multiple organs including the nervous system, limbs, kidneys, heart, and anorectal tract (Koshiba-Takeuchi et al, 2006; Sakaki-Yumoto et al, 2006). Consistent with the phenotypes of SALL4 haploinsufficiency in mice, patients with Okihiro syndrome, an autosomal dominant disorder caused by mutations in SALL4, also present a range of symptoms including limb defects, eye anomalies (Duane syndrome), vertebral malformations, hearing loss, kidney defects, heart anomalies, and anal stenosis (Al-Baradie et al, 2002; Kohlhase et al, 2002). Some Okihiro syndrome patients have a presentation similar to thalidomide embryopathy (Kohlhase et al, 2003); consistent with this, SALL4 is a cellular target of thalidomide, which facilitates binding of SALL4 to the CLR4CRBN E3 ubiquitin ligase that ubiquitylates SALL4 and leads to its destruction (Donovan et al, 2018; Matyskiela et al, 2018, 2020). SALL4 contains seven zinc fingers (Znfs) arranged in three clusters (Fig 1A). Sequence comparisons suggest that these are closely related to zinc finger clusters (ZFCs) 1, 2, and 4 of SALL1 and SALL3 (Sweetman & Munsterberg, 2006). Two SALL4 isoforms have been reported: SALL4A, which encompasses all three ZFCs, and SALL4B, which only has ZFC4. In ESCs, SALL4B is sufficient to maintain ESC identity in the absence of SALL4A (Rao et al, 2010). The roles of ZFC1 and ZFC2 are less well understood. However, SALL4A but not SALL4B can interact with the transcription factor PLZF in spermatogonial progenitor cells, suggesting a role for ZFC1 and/or ZFC2 in protein–protein interactions (Hobbs et al, 2012). Furthermore, ZFC1 and ZFC2 mediate SALL4 ubiquitination in the presence of thalidomide, leading to SALL4 degradation (Matyskiela et al, 2018). ZFC1 was reported to bind to 5-hydroxymethylcytosine (Xiong et al, 2016) and AT-rich DNA sequences in vitro (Ru et al, 2022). However, a SALL4 truncation lacking both ZFC1 and ZFC2 shows no defect in genome-wide chromatin binding in ESCs, suggesting that these ZFCs are largely dispensable for DNA binding in vivo (Pantier et al, 2021). We previously showed that SALL1, SALL3, and SALL4, which all encode ZFC4, are all selectively enriched on AT-rich DNA (Pantier et al, 2021). Similar to observations for SALL1 (Yamashita et al, 2007), ZFC4 of SALL4 is required for its localisation to mouse pericentric heterochromatin (Sakaki-Yumoto et al, 2006) and has a strong preference for a range of AT-rich DNA sequence motifs (Kong et al, 2021; Pantier et al, 2021). The molecular basis of this broad specificity is unknown, but there is evidence that it is essential for the ability of SALL4 to maintain stemness in ESCs by sensing differences in sequence composition in the genome (Pantier et al, 2021). Importantly, discrete mutation of ZFC4 leads to precocious ESC differentiation and embryonic lethality, phenocopying complete loss of SALL4 (Sakaki-Yumoto et al, 2006). To gain insight into how SALL4 selects AT-rich sequences, and the likely effect of missense mutations on DNA binding, we undertook a structural, biochemical, and cell-based analysis of ZFC4. We solved the X-ray crystal structure of SALL4 ZFC4 with an AT-rich sequence motif to gain insight into this broad sequence specificity. We also characterised two patient missense mutations that are likely to be deleterious and causative of Okihiro syndrome. We show that these mutations reduce SALL4 ZFC4 binding to AT-rich DNA, yet the proteins retain preference for AT-rich sequences. In cells, full-length mutant proteins fail to localise to heterochromatin. These results confirm that SALL4 binding to AT-rich sequences is fundamental to its in vivo function and that disruptions to this interaction contribute to disease presentation.
What the sources say
- Supportedcites Pantier et al, 2021 matched to “SALL4 controls cell fate in response to DNA base composition” (2021) source
In Results, the AT-binding protein screen used AT-rich probes against matched controls and recovered SALL1, SALL3, and SALL4 among the proteins selectively binding AT runs. The Results section on ZFC4 states that all three proteins possess that domain. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
81 more claims · 8 with their cited sources checked
Create a free account to see all 138 claims and to verify the 4 references still open.
- It may state two separate claims as one. 44
- Probably not a substantial claim. 11
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115 · cited 1×
“Validation was carried out using MolProbity (Chen et al, 2010) and fi gures were generated using PyMOL (Schrodinger, LLC, 2015).”
UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Pettersen, E. F., Goddard, T. D., Huang, C. C., Meng, E. C., Couch, G. S., Croll, T. I., Morris, J. H., & Ferrin, T. E. (2021) · Protein Science · doi:10.1002/pro.3943 · Cited by 9,514 · cited 1×
“15 ˚ A density maps were generated from each bead model and the corresponding crystal structures docked into this density using ChimeraX (Pettersen et al, 2021).”
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434 · cited 1×
“According to the gnomAD database (Karczewski et al, 2020), the loss-of-function observed/expected upper bound fraction (LOEUF) indicates that SALL4 is depleted of inactivating variants and under purifying selection (LOEUF = 0.101).”
InfluentialProtein Identification and Analysis Tools on the ExPASy Server
Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., Appel, R. D., & Bairoch, A. (2005) · The Proteomics Protocols Handbook · doi:10.1385/1-59259-890-0:571 · Cited by 8,681
ClinVar: improving access to variant interpretations and supporting evidence
Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Jang, W., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1153 · Cited by 4,196 · cited 1×
“…(aa207 – 242) are followed by seven zinc fi nger domains arranged in three clusters (ZFC1, aa382 – 432 ; ZFC2, aa566 – 648 ; and We searched the literature and the ClinVar database for missense variants affecting SALL4 as these can inform on functional regions within SALL4 (Landrum et al, 2018).”
Svergun, D., Barberato, C., & Koch, M. H. J. (1995) · Journal of Applied Crystallography · doi:10.1107/s0021889895007047 · Cited by 3,434
Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., & Smith, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00392-1 · Cited by 3,255 · cited 2×
“To assess the impact of ZFC4 mutation on DNA binding in cells, full-length mouse SALL4 cDNA carrying the WT sequence or patient missense mutations (H898R, R900W, G921D) was cloned into a mammalian expression vector (Chambers et al, 2003) (Fig S5A).”
Research works printed but not linked: 1
- Tickle IJ , Flensburg C , Keller P , Paciorek W , Sharff A , Vonrhein C , Bricogne G (2018) STARANISO. Cambridge, United Kingdom: Global Phasing Ltd.
Cited by
Updated understanding of the protein–DNA recognition code used by C2H2 zinc finger proteins
Zhang, X., Blumenthal, R., & Cheng, X. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2024.102836 · Cited by 41
“H…O-type interactions with Glu [40,56,58] or methyl-specific van der Waals contacts as illustrated by Zfp568 [59] and SALL4 [60,61] (discussed in the following).”
Molecular mechanism, diagnosis, and treatment of VACTERL association
Sun, M., Zhao, Q., Yang, B., et al. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1609624 · Cited by 12
Thalidomide-induced limb malformations: an update and reevaluation
Collins, M. D., & Scott, W. J. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03930-z · Cited by 10
Targeting transcription factors through an IMiD independent zinc finger domain
Liu, B. H., Liu, M., Radhakrishnan, S., Dai, M.-Y., Jaladanki, C. K., Gao, C., Tang, J. P., Kumari, K., Go, M. L., Vu, K. A. L., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00241-3 · Cited by 8
“Recently, the crystal structure of human SALL4 ZFC4 (856 – 930) (Ru et al, 2022) and murine SALL4 ZFC4 (870 – 940) (Watson et al, 2023) were published.”
Koulle, A., Ogundele, O., Shah, D., Baker, I. M., Lopez, M., Lando, D., Reynolds, N., Ragheb, R., Laue, E. D., & Hendrich, B. (2026) · eLife · doi:10.7554/elife.109280 · Cited by 6
Metadata
- Authors
- Watson, J. A., Pantier, R., Jayachandran, U., Chhatbar, K., Alexander-Howden, B., Kruusvee, V., Prendecki, M., Bird, A., & Cook, A. G.
- Affiliations
- Wellcome Centre for Cell Biology (GB)
- University of Copenhagen (DK)
- Wellcome Centre for Cell Biology, Max Born Crescent, Edinburgh, UK
- Corresponding author
- Cook, Atlanta G
- ORCID
- Venue
- Life Science Alliance
- Publisher
- Life Science Alliance, LLC
- Published
- 2023-01-12
- Volume
- 6
- Issue
- 3
- Pages
- e202201588
- ISSN
- 2575-1077 (ISSN-L)
- PMC
- PMC9838217
- OpenAlex
- W4315705236
- Cited by
- 14
- References
- 54
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 1 · 2023: 1
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Life Science Alliance (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (200898, 107930, 092076, 203149)
- EC | ERC | HORIZON EUROPE European Research Council (EC 694295 Gen-Epix)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- SALL4, zinc finger, AT-rich DNA binding, crystal structure, limb development, missense mutations, DNA binding specificity, major groove recognition
- MeSH terms
- Duane Retraction Syndrome, Humans, Mutation, Transcription Factors, Zinc Fingers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.